Sinovac Biotech Ltd (NASDAQ:SVA)

4.98
Delayed Data
As of 11:16am ET
 -0.26 / -4.96%
Today’s Change
4.51
Today|||52-Week Range
5.89
-4.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$292.4M

Company Description

Sinovac Biotech Ltd. is biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza and mumps, as well as animal rabies vaccine. Its products include Healive, Bilive, Anflu, Panflu and PANFLU.1. The company was founded in 1993 and is headquartered in Beijing, China.

Contact Information

Sinovac Biotech Ltd.
No. 39 Shangdi Xi Road
Beijing Beijing 100085
P:861082890088
Investor Relations:
8610827998719659

Employees

Shareholders

Mutual fund holders6.26%
Other institutional19.16%
Individual stakeholders--

Top Executives

Wei Dong YinChairman, President, CEO & Secretary
Nan WangChief Financial Officer
Ming XiaVice President-Sales & Marketing
Xue Feng WangHead-International Sales
Helen G. YangHead-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account